These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24744787)

  • 1. Secondary Acute Myeloid Leukemia in a One-Year-Old Girl Diagnosed with JAK2-V617F Mutation Positive Myeloproliferative Neoplasm.
    Woods GM; Bajwa RP; Kahwash SB; Guinipero T
    Case Rep Med; 2014; 2014():473297. PubMed ID: 24744787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protracted Clonal Trajectory of a
    Langabeer SE; Haslam K; Smyth MA; Quinn J; Murphy PT
    Case Rep Hematol; 2018; 2018():8713020. PubMed ID: 29854499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
    Aynardi J; Manur R; Hess PR; Chekol S; Morrissette JJD; Babushok D; Hexner E; Rogers HJ; Hsi ED; Margolskee E; Orazi A; Hasserjian R; Bagg A
    Br J Haematol; 2018 Jul; 182(1):78-85. PubMed ID: 29767839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
    Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
    Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR.
    Lu Y; Lin L; Lin J; Wu B; Cai G; Wang X; Ma X
    Ann Hematol; 2024 Sep; 103(9):3553-3562. PubMed ID: 39043913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of a patient with
    Jiang YZ; Wei ZL; Wang NN; Huang C; Huang J; Yan JW; Wang R; Yu ZZ; Huang DP
    Hematology; 2022 Dec; 27(1):1290-1293. PubMed ID: 36476114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases.
    Yang YN; Qin YW; Wang C
    Oncol Lett; 2014 Aug; 8(2):841-844. PubMed ID: 25013507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between JAK2
    Brown R; Jasiakiewicz J; Greer V; Hindley A; McDowell K; Devlin E; Clarke K; Buckley F; Crean C; McGimpsey J; Cuthbert RJG; Cunningham N; Arnold C; Finnegan D; Benson G; McMullin MF; Catherwood MA
    Ir J Med Sci; 2024 Aug; ():. PubMed ID: 39138783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: a case report.
    Mamorska-Dyga A; Wu J; Khattar P; Ronny FM; Islam H; Seiter K; Liu D
    Stem Cell Investig; 2016; 3():8. PubMed ID: 27358900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Case of Accelerated-Phase Chronic Myeloid Leukemia Diagnosed During Treatment for JAK2 V617F-Positive Primary Myelofibrosis.
    Ryu J; Chu D; Park B; Kim M; Cho YU; Hwang SH; Jang S; Seo EJ; Lee JH; Park CJ
    Lab Med; 2022 Nov; 53(6):e140-e144. PubMed ID: 35243502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.
    Jekarl DW; Han SB; Kim M; Lim J; Oh EJ; Kim Y; Kim HJ; Min WS; Han K
    Korean J Hematol; 2010 Mar; 45(1):46-50. PubMed ID: 21120162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK2-V617F is a negative regulation factor of SHIP1 protein and thus influences the AKT signaling pathway in patients with Myeloproliferative neoplasm (MPN).
    Glück M; Dally L; Jücker M; Ehm P
    Int J Biochem Cell Biol; 2022 Aug; 149():106229. PubMed ID: 35609769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.
    Ohyashiki JH; Yoneta M; Hisatomi H; Iwabuchi T; Umezu T; Ohyashiki K
    BMC Med Genet; 2012 Jan; 13():6. PubMed ID: 22251709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F.
    Lundberg P; Takizawa H; Kubovcakova L; Guo G; Hao-Shen H; Dirnhofer S; Orkin SH; Manz MG; Skoda RC
    J Exp Med; 2014 Oct; 211(11):2213-30. PubMed ID: 25288396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential thrombocythemia during treatment of acute myeloid leukemia with JAK2 V617F mutation: A case report of a CARE-compliant article.
    Ding W; Li D; Zhuang C; Wei P; Mou W; Zhang L; Liang H; Liu Y
    Medicine (Baltimore); 2018 Jul; 97(27):e11331. PubMed ID: 29979407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera.
    Nagao T; Kurosu T; Umezawa Y; Nogami A; Oshikawa G; Tohda S; Yamamoto M; Miura O
    PLoS One; 2014; 9(1):e84746. PubMed ID: 24404189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLT3 mutations in myeloproliferative neoplasms: the Beaumont experience.
    Williams L; Kelley HH; Meng X; Prada A; Crisan D
    Diagn Mol Pathol; 2013 Sep; 22(3):156-60. PubMed ID: 23846442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low
    Makarik TV; Abdullaev AO; Nikulina EE; Treglazova SA; Stepanova EE; Subortseva IN; Kovrigina AM; Melikyan AL; Kulikov SM; Sudarikov AB
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921387
    [No Abstract]   [Full Text] [Related]  

  • 20. High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms.
    Chatambudza M; Skhosana L; Ketseoglou I; Wiggill T
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.